Low-dose aspirin does not improve ovarian stimulation, endometrial response, or pregnancy rates for in vitro fertilization
- 11k Downloads
The purpose of this study is to determine if low-dose aspirin improved ovarian stimulation, endometrial response, or IVF pregnancy rates in our program.
Retrospective analysis of 316 consecutive IVF cycles from 1995 through 2001. Aspirin 80 mg daily was initiated at the start of luteal leuprolide in 72 cycles. The 244 controls received no aspirin during treatment.
The live birth rate in aspirin users was 29%, slightly lower compared to 41% in the no aspirin control group (p = 0.07). Implantation rates were 21% with aspirin and 30% in the control population (p = 0.01). There was no difference in the maximal endometrial thickness between aspirin and non-aspirin groups. The two groups were similar regarding age, gonadotropin ampules, embryos, number of embryos transferred, prior parity, diagnosis, use of intracytoplasmic sperm injection, and stimulation protocol.
Low-dose aspirin was not beneficial to IVF patients in our program. Aspirin does not enhance endometrial thickness, augment the ovarian response, or improve pregnancy rates.
Keywordsaspirin embryo transfer endometrium fertilization in vitro infertility
We thank Howell Sasser, Ph.D., Director of Research Epidemiology, Dickson Institute at Carolinas Medical Center for his assistance with statistical evaluation.
- 2.Rubinstein M, Marazzi A, Polak de Fried E: Low-dose aspirin treatment improves ovarian responsiveness, uterine and ovarian blood flow velocity, implantation, and pregnancy rates in patients undergoing in vitro fertilization: a prospective, randomized, double-blind placebo-controlled assay. Fertil Steril. 1999, 71: 825-9. 10.1016/S0015-0282(99)00088-6.CrossRefGoogle Scholar
- 9.Hasegawa I, Hamanoto Y, Suzuki M, Murakawa H, Kurabayshi T, Takakuwa K, Tanaka K: Prednisolone plus low-dose aspirin improves the implantation rate in women with autoimmune conditions who are undergoing in vitro fertilization. Fertil Steril. 1998, 70: 1044-8. 10.1016/S0015-0282(98)00343-4.CrossRefGoogle Scholar
- 10.Sher G, Matzner W, Feinman M, Maassarani G, Zouves C, Chong P, Ching W: The selective use of heparin/aspirin therapy, alone or in combination with intravenous immunoglobulin G, in the management of antiphospholipid antibody-positive women undergoing in vitro fertilization. Am J Reprod Immunol. 1998, 40: 74-82.CrossRefGoogle Scholar
- 13.Geva E, Amit A, Lerner-Geva L, Yaron Y, Daniel Y, Schwartz T, Azem F, Yovel I, Lessing JB: Prednisone and aspirin improve pregnancy rate in patients with reproductive failure and autoimmune antibodies: a prospective study. Am J Reprod Immunol. 2000, 43: 36-40. 10.1111/j.8755-8920.2000.430107.x.CrossRefGoogle Scholar
- 15.Stern C, Chamley L, Norris H, Hale L, Baker HW: A randomized, double-blind, placebo-controlled trial of heparin and aspirin for women with in vitro fertilization implantation failure and antiphospholipid or antinuclear antibodies. Fertil Steril. 2003, 80: 376-83. 10.1016/S0015-0282(03)00610-1.CrossRefPubMedGoogle Scholar
- 16.Check JH, Dietterich C, Lurie D, Nazari A, Chuong J: A matched study to determine whether low-dose aspirin without heparin improves pregnancy rates following frozen embryo transfer and/or affects endometrial sonographic parameters. J Assist Reprod Genet. 1998, 15: 579-82. 10.1023/A:1020373009043.CrossRefPubMedCentralPubMedGoogle Scholar
- 19.Triolo G, Ferrante A, Ciccia F, Accardo-Palumbo A, Perino A, Castelli A, Giarratano A, Licata G: Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. Arthritis Rheum. 2003, 48: 728-31. 10.1002/art.10957.CrossRefPubMedGoogle Scholar
- 26.Practice Committee Report: Antiphospholipid antibodies do not affect IVF success. American Society for Reproductive Medicine. 1999Google Scholar
- 27.Rock JA, Hurst BS: Clinical significance of prostanoid concentration in women with endometriosis. Prog Clin Biol Res. 1990, 23: 61-80.Google Scholar
- 32.Sibai BM, Caritis SN, Thom E, Klebanoff M, NcNellis D, Rocco L, Paul RH, Romero R, Witter F, Rosen M, et al: Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. NEJM. 1993, 329: 1213-8. 10.1056/NEJM199310213291701.CrossRefGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.